Allucent is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including regulatory consulting, clinical operations, biostatistics services, and clinical pharmacology across a variety of therapeutic areas.
With more than 30 years of experience in over 70 countries, we have supported over 200 rare and orphan disease clinical studies across a variety of novel therapy classes and precision medicine including; gene therapies, GMO’s, stem cell therapies, and mRNA and antisense therapies. Our individualized partnership approach provides experience-driven insights and expertise to assist clients in successfully navigating the complexities of delivering novel treatments to patients with rare and ultra-rare diseases.
Visit our website for further information, www.allucent.com